Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Revenue for Collegium Pharmaceutical (COLL)
Revenue in 2023 (TTM): $0.56 B
According to Collegium Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $0.56 B. In 2022 the company made a revenue of $0.46 B an increase over the years 2021 revenue that were of $0.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Collegium Pharmaceutical from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.56 B | 22.17% |
| 2022 | $0.46 B | 67.56% |
| 2021 | $0.27 B | -10.69% |
| 2020 | $0.31 B | 4.49% |
| 2019 | $0.29 B | 5.81% |
| 2018 | $0.28 B | 884.73% |
| 2017 | $28.47 M | 1564.29% |
| 2016 | $1.71 M | |
| 2015 | N/A | |
| 2014 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $2.32 B | 310.66% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $19.59 M | -96.54% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $3.64 B | 543.02% | 🇮🇪 Ireland |
 KemPharm KMPH | $10.45 M | -98.15% | 🇺🇸 USA |